Agrovet Market celebrates 31 years transforming animal health through innovation, sustainability, and a global vision

Lima, May 2025. Agrovet Market proudly celebrates its 31st anniversary, marking a trajectory defined by innovation, commitment to animal health, and a sustainable vision focused on the well-being of people and the planet. This milestone reaffirms the company’s leading role in veterinary pharmaceutical industry.

Since its founding in 1994, Agrovet Market has evolved into a regional benchmark, with a presence in over 40 international markets and a portfolio of more than 300 specialized products. Through its Agrovet and Avivet lines, dedicated to production animals, and Petmedica, focused on companion animals, the company responds to the growing demands of a market increasingly conscious of food chain quality and comprehensive pet care.

Driven by a global expansion strategy and a strong commitment to digital transformation, Agrovet Market has optimized its distribution model to provide faster, more personalized, and effective service to clients and partners. This vision is supported by ongoing investment in new technologies, applied research, and highly specialized human talent.

Among its most recent breakthroughs is Atrevia® 360°, the world’s first antiparasitic tablet for dogs that combines extended protection against ectoparasites with internal parasite control, including tapeworms. Launched in 2024, this groundbreaking solution sets a new benchmark in the category, demonstrating the brand’s ability to anticipate trends and deliver disruptive innovations that improve pet quality of life and strengthen veterinarians’ trust.

Complementing its offering for companion animal health, Agrovet Market has also launched Petnutri, a new division providing premium pet food brands that reinforce a holistic approach to health through nutrition.

Beyond its portfolio, Agrovet Market’s purpose is rooted in a clear conviction: Animal health is essential to the well-being of people and the planet.